Early research (Phase 1)UnknownNCT03634982What this trial is testingDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)Ended earlyNCT04718675What this trial is testingKB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)Who this might be right forRelapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more Kronos Bio 135
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)Study completedNCT00782145What this trial is testingA Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Tufts Medical Center 198
Testing effectiveness (Phase 2)Ended earlyNCT01296035What this trial is testingPanitumumab and Gemcitabine in Relapsed Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Women and Infants Hospital of Rhode Island 8
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Early research (Phase 1)Active Not RecruitingNCT04511871What this trial is testingA Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid TumorsWho this might be right forSolid TumorGastric CancerBreast Cancer+2 more Shanghai PerHum Therapeutics Co., Ltd. 12
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03997968What this trial is testingCYT-0851 in B-Cell Malignancies and Advanced Solid TumorsWho this might be right forMalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT00010283What this trial is testingBeclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Very early researchUnknownNCT05801783What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian CancerWho this might be right forOvarian CancerPeritoneal CarcinomatosisFallopian Tube Cancer Shanghai Yunying Medical Technology 10
Not applicableStudy completedNCT05372692What this trial is testingStudy of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian CancerWho this might be right forOvarian Cancer Weijia Fang, MD 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670312What this trial is testingEvaluation of XYA02 in Patients With Advanced Solid TumorsWho this might be right forMUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+3 more XYone Therapeutics, Inc 190
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00445731What this trial is testingA Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forCancer University of Minnesota 115
Early research (Phase 1)Study completedNCT00303940What this trial is testingTalabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Study completedNCT03029598What this trial is testingPembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma University of Washington 29
Not applicableStudy completedNCT00293384What this trial is testingAprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00002903What this trial is testingDocetaxel in Treating Patients With Recurrent or Refractory Germ Cell CancerWho this might be right forExtragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor European Organisation for Research and Treatment of Cancer - EORTC 25